Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

ICLR vs PRA

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ICLR
ICON Public Limited Company

Medical - Diagnostics & Research

HealthcareNASDAQ • IE
Market Cap$9.51B
5Y Perf.-26.1%
PRA
ProAssurance Corporation

Insurance - Property & Casualty

Financial ServicesNYSE • US
Market Cap$1.27B
5Y Perf.+79.0%

ICLR vs PRA — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ICLR logoICLR
PRA logoPRA
IndustryMedical - Diagnostics & ResearchInsurance - Property & Casualty
Market Cap$9.51B$1.27B
Revenue (TTM)$8.10B$1.08B
Net Income (TTM)$599M$65M
Gross Margin26.9%25.5%
Operating Margin12.2%8.4%
Forward P/E10.7x21.7x
Total Debt$3.60B$435M
Cash & Equiv.$539M$36M

ICLR vs PRALong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ICLR
PRA
StockMay 20May 26Return
ICON Public Limited… (ICLR)10073.9-26.1%
ProAssurance Corpor… (PRA)100179.0+79.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: ICLR vs PRA

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ICLR leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. ProAssurance Corporation is the stronger pick specifically for capital preservation and lower volatility and recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ICLR
ICON Public Limited Company
The Growth Play

ICLR carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 2.0%, EPS growth 28.8%, 3Y rev CAGR 14.8%
  • 90.2% 10Y total return vs PRA's -18.6%
  • 2.0% revenue growth vs PRA's -2.7%
Best for: growth exposure and long-term compounding
PRA
ProAssurance Corporation
The Insurance Pick

PRA is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 0 yrs, beta 0.05
  • Lower volatility, beta 0.05, Low D/E 32.2%, current ratio 1.33x
  • Beta 0.05, current ratio 1.33x
Best for: income & stability and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthICLR logoICLR2.0% revenue growth vs PRA's -2.7%
ValueICLR logoICLRLower P/E (10.7x vs 21.7x)
Quality / MarginsICLR logoICLR7.4% margin vs PRA's 6.0%
Stability / SafetyPRA logoPRABeta 0.05 vs ICLR's 1.64, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)PRA logoPRA+7.8% vs ICLR's -10.1%
Efficiency (ROA)ICLR logoICLR3.6% ROA vs PRA's 1.2%, ROIC 6.5% vs 3.2%

ICLR vs PRA — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ICLRICON Public Limited Company
FY 2012
Clinical Research
92.2%$1.0B
Central Laboratory
7.8%$87M
PRAProAssurance Corporation
FY 2025
Specialty Property and Casualty
77.5%$724M
Workers' Compensation Insurance Segment
17.6%$164M
Segregated Portfolio Cell Reinsurance
4.9%$46M

ICLR vs PRA — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLICLRLAGGINGPRA

Income & Cash Flow (Last 12 Months)

ICLR leads this category, winning 5 of 6 comparable metrics.

ICLR is the larger business by revenue, generating $8.1B annually — 7.5x PRA's $1.1B. Profitability is closely matched — net margins range from 7.4% (ICLR) to 6.0% (PRA).

MetricICLR logoICLRICON Public Limit…PRA logoPRAProAssurance Corp…
RevenueTrailing 12 months$8.1B$1.1B
EBITDAEarnings before interest/tax$1.4B$101M
Net IncomeAfter-tax profit$599M$65M
Free Cash FlowCash after capex$996M-$17M
Gross MarginGross profit ÷ Revenue+26.9%+25.5%
Operating MarginEBIT ÷ Revenue+12.2%+8.4%
Net MarginNet income ÷ Revenue+7.4%+6.0%
FCF MarginFCF ÷ Revenue+12.3%-1.6%
Rev. Growth (YoY)Latest quarter vs prior year+0.6%-2.0%
EPS Growth (YoY)Latest quarter vs prior year-98.7%+2.5%
ICLR leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

ICLR leads this category, winning 4 of 5 comparable metrics.

At 13.1x trailing earnings, ICLR trades at a 48% valuation discount to PRA's 24.9x P/E. On an enterprise value basis, ICLR's 7.9x EV/EBITDA is more attractive than PRA's 19.5x.

MetricICLR logoICLRICON Public Limit…PRA logoPRAProAssurance Corp…
Market CapShares × price$9.5B$1.3B
Enterprise ValueMkt cap + debt − cash$12.6B$1.7B
Trailing P/EPrice ÷ TTM EPS13.06x24.95x
Forward P/EPrice ÷ next-FY EPS est.10.73x21.73x
PEG RatioP/E ÷ EPS growth rate1.86x
EV / EBITDAEnterprise value multiple7.92x19.51x
Price / SalesMarket cap ÷ Revenue1.15x1.16x
Price / BookPrice ÷ Book value/share1.09x0.95x
Price / FCFMarket cap ÷ FCF8.50x
ICLR leads this category, winning 4 of 5 comparable metrics.

Profitability & Efficiency

ICLR leads this category, winning 5 of 9 comparable metrics.

ICLR delivers a 6.3% return on equity — every $100 of shareholder capital generates $6 in annual profit, vs $5 for PRA. PRA carries lower financial leverage with a 0.32x debt-to-equity ratio, signaling a more conservative balance sheet compared to ICLR's 0.38x. On the Piotroski fundamental quality scale (0–9), ICLR scores 7/9 vs PRA's 3/9, reflecting strong financial health.

MetricICLR logoICLRICON Public Limit…PRA logoPRAProAssurance Corp…
ROE (TTM)Return on equity+6.3%+5.0%
ROA (TTM)Return on assets+3.6%+1.2%
ROICReturn on invested capital+6.5%+3.2%
ROCEReturn on capital employed+7.8%+4.0%
Piotroski ScoreFundamental quality 0–973
Debt / EquityFinancial leverage0.38x0.32x
Net DebtTotal debt minus cash$3.1B$399M
Cash & Equiv.Liquid assets$539M$36M
Total DebtShort + long-term debt$3.6B$435M
Interest CoverageEBIT ÷ Interest expense3.96x4.53x
ICLR leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

PRA leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in PRA five years ago would be worth $10,016 today (with dividends reinvested), compared to $5,523 for ICLR. Over the past 12 months, PRA leads with a +7.8% total return vs ICLR's -10.1%. The 3-year compound annual growth rate (CAGR) favors PRA at 9.8% vs ICLR's -13.1% — a key indicator of consistent wealth creation.

MetricICLR logoICLRICON Public Limit…PRA logoPRAProAssurance Corp…
YTD ReturnYear-to-date-34.0%+2.8%
1-Year ReturnPast 12 months-10.1%+7.8%
3-Year ReturnCumulative with dividends-34.4%+32.4%
5-Year ReturnCumulative with dividends-44.8%+0.2%
10-Year ReturnCumulative with dividends+90.2%-18.6%
CAGR (3Y)Annualised 3-year return-13.1%+9.8%
PRA leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

PRA leads this category, winning 2 of 2 comparable metrics.

PRA is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than ICLR's 1.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PRA currently trades 99.4% from its 52-week high vs ICLR's 59.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricICLR logoICLRICON Public Limit…PRA logoPRAProAssurance Corp…
Beta (5Y)Sensitivity to S&P 5001.64x0.05x
52-Week HighHighest price in past year$211.00$24.85
52-Week LowLowest price in past year$66.57$22.72
% of 52W HighCurrent price vs 52-week peak+59.0%+99.4%
RSI (14)Momentum oscillator 0–10062.849.1
Avg Volume (50D)Average daily shares traded1.1M798K
PRA leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates ICLR as "Buy" and PRA as "Hold". Consensus price targets imply 22.2% upside for ICLR (target: $152) vs -25.8% for PRA (target: $18).

MetricICLR logoICLRICON Public Limit…PRA logoPRAProAssurance Corp…
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$152.13$18.33
# AnalystsCovering analysts3011
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+5.3%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

ICLR leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). PRA leads in 2 (Total Returns, Risk & Volatility).

Best OverallICON Public Limited Company (ICLR)Leads 3 of 6 categories
Loading custom metrics...

ICLR vs PRA: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is ICLR or PRA a better buy right now?

For growth investors, ICON Public Limited Company (ICLR) is the stronger pick with 2.

0% revenue growth year-over-year, versus -2. 7% for ProAssurance Corporation (PRA). ICON Public Limited Company (ICLR) offers the better valuation at 13. 1x trailing P/E (10. 7x forward), making it the more compelling value choice. Analysts rate ICON Public Limited Company (ICLR) a "Buy" — based on 30 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ICLR or PRA?

On trailing P/E, ICON Public Limited Company (ICLR) is the cheapest at 13.

1x versus ProAssurance Corporation at 24. 9x. On forward P/E, ICON Public Limited Company is actually cheaper at 10. 7x.

03

Which is the better long-term investment — ICLR or PRA?

Over the past 5 years, ProAssurance Corporation (PRA) delivered a total return of +0.

2%, compared to -44. 8% for ICON Public Limited Company (ICLR). Over 10 years, the gap is even starker: ICLR returned +90. 2% versus PRA's -18. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ICLR or PRA?

By beta (market sensitivity over 5 years), ProAssurance Corporation (PRA) is the lower-risk stock at 0.

05β versus ICON Public Limited Company's 1. 64β — meaning ICLR is approximately 3233% more volatile than PRA relative to the S&P 500. On balance sheet safety, ProAssurance Corporation (PRA) carries a lower debt/equity ratio of 32% versus 38% for ICON Public Limited Company — giving it more financial flexibility in a downturn.

05

Which is growing faster — ICLR or PRA?

By revenue growth (latest reported year), ICON Public Limited Company (ICLR) is pulling ahead at 2.

0% versus -2. 7% for ProAssurance Corporation (PRA). On earnings-per-share growth, the picture is similar: ICON Public Limited Company grew EPS 28. 8% year-over-year, compared to -3. 9% for ProAssurance Corporation. Over a 3-year CAGR, ICLR leads at 14. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ICLR or PRA?

ICON Public Limited Company (ICLR) is the more profitable company, earning 9.

6% net margin versus 4. 6% for ProAssurance Corporation — meaning it keeps 9. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ICLR leads at 13. 3% versus 6. 6% for PRA. At the gross margin level — before operating expenses — PRA leads at 39. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ICLR or PRA more undervalued right now?

On forward earnings alone, ICON Public Limited Company (ICLR) trades at 10.

7x forward P/E versus 21. 7x for ProAssurance Corporation — 11. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ICLR: 22. 2% to $152. 13.

08

Which pays a better dividend — ICLR or PRA?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is ICLR or PRA better for a retirement portfolio?

For long-horizon retirement investors, ProAssurance Corporation (PRA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

05)). ICON Public Limited Company (ICLR) carries a higher beta of 1. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PRA: -18. 6%, ICLR: +90. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ICLR and PRA?

These companies operate in different sectors (ICLR (Healthcare) and PRA (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ICLR is a small-cap deep-value stock; PRA is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

ICLR

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Stocks Like

PRA

Quality Business

  • Sector: Financial Services
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ICLR and PRA on the metrics below

Revenue Growth>
%
(ICLR: 0.6% · PRA: -2.0%)
Net Margin>
%
(ICLR: 7.4% · PRA: 6.0%)
P/E Ratio<
x
(ICLR: 13.1x · PRA: 24.9x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.